This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Valeant Pharmaceuticals International, Inc.
Drug Names(s): aminocaproic acid
Description: Caprogel is a topical formulation containing aminocaproic acid which inhibits the activation of plasminogen. Plasminogen dissolves blood clots; its inhibition promotes blot clotting and prevents further bleeding.
This product was originally developed by ISTA. In June 2012, Bausch and Lomb completed its acquisition of ISTA.
Bausch + Lomb and Valeant
In May 2013, Valeant and Bausch + Lomb announced that they have entered into a definitive agreement under which Valeant will acquire Bausch + Lomb for $8.7 billion in cash.
In August 2013, Valeant announced it has completed the acquisition of Bausch + Lomb.
Pink Sheet Trademark Review
Additional information available to subscribers only: